Label Value
DOI 10.1038/s41375-018-0276-9
TITLE Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-10-23T02:18:30.561991
Web of Science Yes 2019-04-16T03:28:09.781958
Compendex No 2020-10-15T19:15:13.454157